Foundation Models for IVF
Foundation models and the fertility arms race
Nature Communications published a foundation model for IVF trained on large-scale time-lapse embryo images. The goal: standardized, non-invasive embryo assessment that reduces variability in grading across clinics. Luxury enters because many clinics already differentiate on "tech-forward" embryo assessment, and marginal gains matter enormously when patients pay tens of thousands per cycle.
Beyond "AI Picks Embryos"
The deeper questions: How do models generalize across clinics and imaging setups? Does performance vary by lab protocols? Does commercial deployment push clinics toward standardization (potentially good) or create black-box dependency (potentially risky)?
Recent randomized trials show that AI embryo selection is not yet clearly superior to experienced embryologists; non-inferiority was not demonstrated in a multi-clinic RCT. For patients spending heavily on IVF cycles, these technical details translate directly to hope and heartbreak.
Why It Matters for Luxury
IVF is already a luxury health service for many—expensive, emotionally intense, with uncertain outcomes. AI embryo selection promises to improve those odds, and clinics compete on technological sophistication. The stakes are uniquely personal: this isn't abstract health data but the potential for a child. That emotional weight amplifies both the appeal and the responsibility of AI in fertility.
Research
- A foundational model for IVF embryo assessment (Nature Communications, 2025)
- Deep learning vs. embryologists RCT (Nature Medicine, 2024) — Multi-clinic non-inferiority trial
- AI to personalize ART (npj Digital Medicine, 2024) — Review of AI in ovarian stimulation, gamete selection, and embryo assessment
News & Coverage
- Alife Health: LOTUS study completion (2024) — U.S. randomized trial of AI embryo selection — July 2024